67 related articles for article (PubMed ID: 26890683)
1. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador.
Cremer ML; Maza M; Alfaro KM; Kim JJ; Ditzian LR; Villalta S; Alonzo TA; Felix JC; Castle PE; Gage JC
J Low Genit Tract Dis; 2016 Apr; 20(2):145-50. PubMed ID: 26890683
[TBL] [Abstract][Full Text] [Related]
2. Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.
Cremer M; Maza M; Alfaro K; Morales Velado M; Felix J; Castle PE; Kim J; Gage JC
J Low Genit Tract Dis; 2017 Jan; 21(1):26-32. PubMed ID: 27922905
[TBL] [Abstract][Full Text] [Related]
3. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
[TBL] [Abstract][Full Text] [Related]
4. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.
Campos NG; Alfaro K; Maza M; Sy S; Melendez M; Masch R; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M; Kim JJ
Prev Med; 2020 Feb; 131():105931. PubMed ID: 31765712
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
[TBL] [Abstract][Full Text] [Related]
7. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
Pimple S; Shastri SS
Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
[TBL] [Abstract][Full Text] [Related]
9. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador.
Alfaro K; Maza M; Felix JC; Gage JC; Castle PE; Alonzo TA; Chacón A; González E; Soler M; Conzuelo-Rodriguez G; Masch R; Cremer M
JCO Glob Oncol; 2020 Oct; 6():1519-1530. PubMed ID: 33064628
[TBL] [Abstract][Full Text] [Related]
10. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
11. Mexican Cervical Cancer Screening Study II: 6-month and 2-year follow-up of HR-HPV women treated with cryotherapy in a low-resource setting.
Starks D; Arriba LN; Enerson CL; Brainard J; Nagore N; Chiesa-Vottero A; Uribe JV; Belinson J
J Low Genit Tract Dis; 2014 Oct; 18(4):333-7. PubMed ID: 24977628
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India.
Basu P; Mittal S; Banerjee D; Singh P; Panda C; Dutta S; Mandal R; Das P; Biswas J; Muwonge R; Sankaranarayanan R
Int J Cancer; 2015 Aug; 137(4):859-67. PubMed ID: 25631198
[TBL] [Abstract][Full Text] [Related]
13. Use of electronic health record-based tools to improve appropriate use of the human papillomavirus test in adult women.
Broach V; Day L; Barenberg B; Huang S; Kenton K; White P
J Low Genit Tract Dis; 2014 Jan; 18(1):26-30. PubMed ID: 23959296
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
[TBL] [Abstract][Full Text] [Related]
15. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
[TBL] [Abstract][Full Text] [Related]
16. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
17. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
18. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program.
Alfaro KM; Gage JC; Rosenbaum AJ; Ditzian LR; Maza M; Scarinci IC; Miranda E; Villalta S; Felix JC; Castle PE; Cremer ML
BMC Public Health; 2015 Oct; 15():1058. PubMed ID: 26474762
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting.
Banerjee D; Mandal R; Mandal A; Ghosh I; Mittal S; Muwonge R; Lucas E; Basu P
Asian Pac J Cancer Prev; 2020 May; 21(5):1391-1398. PubMed ID: 32458647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
